<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xml:base="http://www.insureintell.com/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title></title>
    <link>http://www.insureintell.com/</link>
    <description></description>
    <language>en</language>
          <item>
    <title>The Significance of Hemoglobin A1C Levels in Nondiabetics (Munich RE)</title>
    <link>http://www.insureintell.com/node/24655</link>
    <description>&lt;p&gt;It has been demonstrated that the development of microvascular complications of diabetes mellitus, especially diabetic retinopathy, can be delayed by establishing more strict glycemic control. As a result, methods of monitoring glycemic control by measuring the amount of glucose attached to various proteins in the blood have been developed.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.munichre.com/site/marclife-mobile/get/documents_E1772416219/marclife/assset.marclife/Documents/Publications/hemoglobin-WP-1-4-17.pdf&quot; title=&quot;https://www.munichre.com/site/marclife-mobile/get/documents_E1772416219/marclife/assset.marclife/Documents/Publications/hemoglobin-WP-1-4-17.pdf&quot;&gt;https://www.munichre.com/site/marclife-mobile/get/documents_E1772416219/...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/taxonomy/term/2371">Hemoglobin A1C</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/insurance-medicine">Insurance Medicine</category>
 <category domain="http://www.insureintell.com/category/tags/life">Life</category>
 <category domain="http://www.insureintell.com/taxonomy/term/2372">nondiabetics</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/underwriting">Underwriting</category>
 <pubDate>Sun, 26 Feb 2017 20:40:11 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24655 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Medical Underwriting: The Race against Antibiotic Resistance (RGA)</title>
    <link>http://www.insureintell.com/node/24654</link>
    <description>&lt;p&gt;Are Miracle Drugs Being Outmatched by Superbugs?&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.rgare.com/knowledge-center/media/articles/the-race-against-antibiotic-resistance&quot; title=&quot;http://www.rgare.com/knowledge-center/media/articles/the-race-against-antibiotic-resistance&quot;&gt;http://www.rgare.com/knowledge-center/media/articles/the-race-against-an...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/taxonomy/term/2370">antibiotic resistance</category>
 <category domain="http://www.insureintell.com/taxonomy/term/2343">drugs</category>
 <category domain="http://www.insureintell.com/category/articles-journalscan-hotnotes/medical-underwriting">Medical Underwriting</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/underwriting">Underwriting</category>
 <pubDate>Sun, 26 Feb 2017 20:38:19 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24654 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Middle Market Life Insurance: Findings from Industry Leaders</title>
    <link>http://www.insureintell.com/node/24653</link>
    <description>&lt;p&gt;The Society of Actuaries’ Marketing and Distribution Section (MAD) announce the release of a new report on the middle-income life insurance market.  Success has been limited in this market even though over the last 10 years, a number of studies and ideas have been presented as viable strategies for serving the middle market. Authored by Doug Bennett with assistance from Stephen Camilli of ACTEX Learning, this report seeks to understand this lack of success and document the experiences of companies and distributors with significant working knowledge of the middle-income market.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.soa.org/Research/Research-Projects/Life-Insurance/middle-market-findings.aspx&quot; title=&quot;https://www.soa.org/Research/Research-Projects/Life-Insurance/middle-market-findings.aspx&quot;&gt;https://www.soa.org/Research/Research-Projects/Life-Insurance/middle-mar...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/category/tags/life">Life</category>
 <category domain="http://www.insureintell.com/category/tags/marketing">marketing</category>
 <category domain="http://www.insureintell.com/category/tags/middle-market">middle market</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/selling">Selling</category>
 <category domain="http://www.insureintell.com/category/tags/simplified-life-insurance">simplified life insurance</category>
 <pubDate>Sun, 26 Feb 2017 20:37:20 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24653 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Life Insurance Challenges Posed by Marijuana and E-cigarettes</title>
    <link>http://www.insureintell.com/node/24652</link>
    <description>&lt;p&gt;An increasingly discussed area in life insurance circles is the manner in which marijuana and e-cigarettes are addressed by life insurance carriers.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.lifehealthpro.com/2017/02/13/life-insurance-challenges-posed-by-marijuana-and-e?page_all=1&quot; title=&quot;http://www.lifehealthpro.com/2017/02/13/life-insurance-challenges-posed-by-marijuana-and-e?page_all=1&quot;&gt;http://www.lifehealthpro.com/2017/02/13/life-insurance-challenges-posed-...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/category/tags/e-cigarettes">e-cigarettes</category>
 <category domain="http://www.insureintell.com/category/tags/insurability">insurability</category>
 <category domain="http://www.insureintell.com/category/tags/life">Life</category>
 <category domain="http://www.insureintell.com/category/tags/marijuana">marijuana</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/underwriting">Underwriting</category>
 <pubDate>Sun, 26 Feb 2017 20:36:41 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24652 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Insurers Shouldn’t Stigmatize Epilepsy (Gen Re)</title>
    <link>http://www.insureintell.com/node/24651</link>
    <description>&lt;p&gt;Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications for life and health insurance because it is associated with loss of productivity, increased healthcare needs and even premature death.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.genre.com/knowledge/blog/insurers-shouldnt-stigmatize-epilepsy-en.html&quot; title=&quot;http://www.genre.com/knowledge/blog/insurers-shouldnt-stigmatize-epilepsy-en.html&quot;&gt;http://www.genre.com/knowledge/blog/insurers-shouldnt-stigmatize-epileps...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/category/tags/epilepsy">epilepsy</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/health">Health</category>
 <category domain="http://www.insureintell.com/category/tags/insurability">insurability</category>
 <category domain="http://www.insureintell.com/category/tags/life">Life</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/underwriting">Underwriting</category>
 <pubDate>Sun, 26 Feb 2017 20:35:41 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24651 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>SCORacle UK Life Newsletter Issue 7</title>
    <link>http://www.insureintell.com/node/24650</link>
    <description>&lt;p&gt;Welcome to the 7th edition of SCORacle, which contains some variation to the usual Underwriting and Claims focus and includes articles by 3 young students that spent some time with SCOR in the summer to provide their views of our industry. This provides a fascinating insight into the thoughts of our consumers of the future. In addition, we also have some interesting information from our Consultant Cardiologist on two commonly seen conditions that from an underwriting perspective we should keep an eye on and for our readers who are Claims assessors, we include some information relating to changes to death certification.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.scor.com/images/stories/pdf/library/newsletter/SCORACLE_7_Dec2016.pdf&quot; title=&quot;https://www.scor.com/images/stories/pdf/library/newsletter/SCORACLE_7_Dec2016.pdf&quot;&gt;https://www.scor.com/images/stories/pdf/library/newsletter/SCORACLE_7_De...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/category/tags/cardiovascular-disease">cardiovascular disease</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/claims">Claims</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/global-industry">Global Industry</category>
 <category domain="http://www.insureintell.com/category/tags/life">Life</category>
 <category domain="http://www.insureintell.com/category/tags/millennials">millennials</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/technology">Technology</category>
 <pubDate>Sun, 26 Feb 2017 20:34:57 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24650 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Medical Underwriting: UPDATED Marijuana - Not Just Blowing Smoke (RGA)</title>
    <link>http://www.insureintell.com/node/24649</link>
    <description>&lt;p&gt;Legal “pot” use is no longer a pipe dream. Although marijuana remains the most commonly consumed illegal drug1 in the world, many nations and at least 28 U.S. states and the District of Columbia have decriminalized its medicinal use, and efforts to liberalize recreational consumption continue to gain momentum.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.rgare.com/knowledge-center/media/research/marijuana-not-just-blowing-smoke&quot; title=&quot;http://www.rgare.com/knowledge-center/media/research/marijuana-not-just-blowing-smoke&quot;&gt;http://www.rgare.com/knowledge-center/media/research/marijuana-not-just-...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/taxonomy/term/2343">drugs</category>
 <category domain="http://www.insureintell.com/category/tags/marijuana">marijuana</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/underwriting">Underwriting</category>
 <pubDate>Sun, 26 Feb 2017 20:33:47 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24649 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>Five Myths and Facts about Artificial Intelligence (SOA)</title>
    <link>http://www.insureintell.com/node/24648</link>
    <description>&lt;p&gt;Artificial intelligence (AI) is splashed throughout the headlines these days. AI recently beat the human Go champion, autonomous cars can drive themselves, social bots can mimic human interactions and converse with others in social networks, and AI totally manages some hedge funds.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.soa.org/sections/pred-analytics-futurism/pred-analytics-futurism-newsletter/&quot; title=&quot;https://www.soa.org/sections/pred-analytics-futurism/pred-analytics-futurism-newsletter/&quot;&gt;https://www.soa.org/sections/pred-analytics-futurism/pred-analytics-futu...&lt;/a&gt;&lt;br /&gt;
&lt;strong&gt;&lt;em&gt;Article appears in Issue 14 on page 14&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/taxonomy/term/2368">AI</category>
 <category domain="http://www.insureintell.com/taxonomy/term/2369">artificial intelligence</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/technology">Technology</category>
 <pubDate>Sun, 26 Feb 2017 20:32:49 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24648 at http://www.insureintell.com</guid>
  </item>
  <item>
    <title>HIV Infection: Ageing, Inflammation and Comorbidities (SCOR inFORM)</title>
    <link>http://www.insureintell.com/node/24647</link>
    <description>&lt;p&gt;From the end of the 2000s, after the introduction of the first antiretroviral therapies (ART), it became clear that the benefits of these treatments were considerably greater than their side effects, especially when introduced early. The recommendation at present is to begin treatment with ART as soon as CD4 T-cell count falls below the normal level of 500/mm3.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://www.scor.com/images/stories/pdf/library/scor-inform/SCOR_in_FORM_VIH_Infla_Comorbidit_EN.pdf&quot; title=&quot;https://www.scor.com/images/stories/pdf/library/scor-inform/SCOR_in_FORM_VIH_Infla_Comorbidit_EN.pdf&quot;&gt;https://www.scor.com/images/stories/pdf/library/scor-inform/SCOR_in_FORM...&lt;/a&gt;&lt;/p&gt;
</description>
     <category domain="http://www.insureintell.com/category/tags/hiv">HIV</category>
 <category domain="http://www.insureintell.com/category/wordpress-category/ltc">LTC</category>
 <category domain="http://www.insureintell.com/category/tags/morbidity">morbidity</category>
 <pubDate>Sun, 26 Feb 2017 20:31:24 +0000</pubDate>
 <dc:creator>matt</dc:creator>
 <guid isPermaLink="false">24647 at http://www.insureintell.com</guid>
  </item>
  </channel>
</rss>
